Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07262749

Intraperitoneal Gas Drainage to Reduce Postoperative Shoulder Pain After Gynecologic Laparoscopy .

This randomized controlled trial aims to evaluate whether the use of an intraperitoneal gas drain at the end of gynecologic laparoscopic surgery can reduce postoperative shoulder pain. Residual carbon dioxide after laparoscopy is believed to irritate the diaphragm and cause referred shoulder pain, which is a common and distressing postoperative symptom. Women undergoing gynecologic laparoscopy lasting more than 20 minutes will be randomized to receive either an intraperitoneal drain for passive gas evacuation or standard care without a drain. Shoulder pain, abdominal pain, analgesic consumption, postoperative nausea and vomiting, and recovery indicators will be assessed during the first 48 hours after surgery.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Post-laparoscopic shoulder pain is a frequent complaint after gynecologic laparoscopy and is mainly attributed to residual carbon dioxide retained in the peritoneal cavity, which irritates the diaphragm and stimulates the phrenic nerve. This study is designed to investigate a simple mechanical intervention-placement of an intraperitoneal gas drain-to facilitate passive evacuation of carbon dioxide and potentially reduce postoperative pain.

Women undergoing gynecologic laparoscopy lasting more than 20 minutes at the Department of Obstetrics and Gynecology, Women's Health University Hospital, Assiut University, will be recruited and randomized into two equal groups. The intervention group will receive a plastic intraperitoneal drain placed through the umbilical port and left in situ for 24 hours postoperatively. The control group will undergo standard gas evacuation without drain placement.

Pain will be assessed using a 10-cm Visual Analog Scale (VAS) at recovery, 6, 12, 24, and 48 hours postoperatively for both shoulder and abdominal pain. Secondary outcomes include total analgesic consumption within 48 hours, incidence of postoperative nausea and vomiting, time to return of intestinal sounds, and time to first mobilization. The primary outcome is the mean shoulder pain score at 24 hours.

This trial aims to provide high-quality evidence on the effectiveness of intraperitoneal gas drainage in reducing postoperative discomfort following gynecologic laparoscopy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women undergoing gynecologic laparoscopy lasting more than 20 minutes.
  • Able and willing to provide informed consent.

Exclusion criteria

  • Refusal to participate.
  • Patients unable to give consent or unable to participate in pain assessment.

Treatment and study plan

Intraperitoneal Gas Drain

Other

A plastic intraperitoneal drain is placed through the umbilical port at the end of laparoscopic surgery and left in situ for 24 hours to allow passive evacuation of carbon dioxide. This aims to reduce diaphragmatic irritation and postoperative shoulder pain.

Primary outcomes

  1. Severity of postoperative shoulder pain using the Visual Analog Scale (VAS)

    Time frame: At 24 hours after surgery

    Shoulder pain severity will be assessed using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.

Secondary outcomes

  1. Postoperative shoulder pain (VAS) at 6 hours

    Time frame: At 6 hours after surgery

    Pain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.

  2. Postoperative shoulder pain (VAS) at 12 hours

    Time frame: At 12 hours after surgery

    Pain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.

  3. Postoperative shoulder pain (VAS) at 24 hours

    Time frame: At 24 hours after surgery

    Pain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.

  4. Postoperative shoulder pain (VAS) at 48 hours

    Time frame: At 48 hours after surgery

    Pain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.

  5. Total analgesic consumption within 48 hours

    Time frame: Up to 48 hours after surgery

    Total amount of opioids and NSAIDs administered during the first 48 hours after surgery will be recorded.

  6. Incidence of postoperative nausea and vomiting

    Time frame: Up to 48 hours after surgery

    Number of participants experiencing nausea and/or vomiting within 48 hours after surgery.

  7. Time to return of bowel sounds

    Time frame: Up to 48 hours after surgery

    Time from end of surgery until the first documented return of bowel sounds.

  8. Time to first mobilization

    Time frame: Up to 48 hours after surgery

    Time from end of surgery until first ambulation.

Study contacts

Contact information is provided by the study sponsor or research team.

Abdulrahmen Mohamed Rageh, MD

CONTACT

[email protected]

+20 100 505 6259

Mohamed Shehata Mohamed Osman

CONTACT

[email protected]

01015530934

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Effect of Intraperitoneal Gas Drain on Postoperative Pain After Gynecologic Laparoscopy: A Randomized Controlled Trial.

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Dec 4, 2025
Registry last updated
Dec 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.